Does PEMBROLIZUMAB Cause Dermatitis bullous? 136 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 136 reports of Dermatitis bullous have been filed in association with PEMBROLIZUMAB (KEYTRUDA). This represents 0.2% of all adverse event reports for PEMBROLIZUMAB.
136
Reports of Dermatitis bullous with PEMBROLIZUMAB
0.2%
of all PEMBROLIZUMAB reports
7
Deaths
79
Hospitalizations
How Dangerous Is Dermatitis bullous From PEMBROLIZUMAB?
Of the 136 reports, 7 (5.1%) resulted in death, 79 (58.1%) required hospitalization, and 16 (11.8%) were considered life-threatening.
Is Dermatitis bullous Listed in the Official Label?
Yes, Dermatitis bullous is listed as a known adverse reaction in the official FDA drug label for PEMBROLIZUMAB.
What Other Side Effects Does PEMBROLIZUMAB Cause?
Malignant neoplasm progression (10,111)
Death (4,744)
Diarrhoea (4,251)
Fatigue (3,833)
Off label use (3,416)
Product use in unapproved indication (3,191)
Pyrexia (3,155)
Rash (2,900)
Nausea (2,670)
Decreased appetite (2,486)
What Other Drugs Cause Dermatitis bullous?
LINAGLIPTIN (275)
ACETAMINOPHEN (157)
IBUPROFEN (142)
FUROSEMIDE (140)
METHOTREXATE (129)
VANCOMYCIN (115)
CARBOPLATIN (105)
ESOMEPRAZOLE (103)
NIVOLUMAB (103)
AMOXICILLIN (100)
Which PEMBROLIZUMAB Alternatives Have Lower Dermatitis bullous Risk?
PEMBROLIZUMAB vs PEMETREXED
PEMBROLIZUMAB vs PEMIGATINIB
PEMBROLIZUMAB vs PENICILLAMINE
PEMBROLIZUMAB vs PENICILLIN
PEMBROLIZUMAB vs PENICILLIN G